Neoantigen Derived DCs as Cancer Treatment

Approximately 1.5 x 10\^6±20% cells will be subcutaneously injected to the patient's inguinal area (either left side or right side can be injected, only one area will be injected each time) on day 1, 8, 15, 29, 85, 141, 197, 253 and 309.

Lenvatinib 10mg/day on day 43-77

Nivolumab 3mg/kg on day 43, 57 and 71.